- Home
- Publications
- Publication Search
- Publication Details
Title
Acne inversa
Authors
Keywords
Hidradenitis suppurativa, Operative Therapie, Rezidivrate, Lebensqualität, Exzision, Hidradenitis suppurativa, Surgery, Recurrence rate, Quality of life, Excision
Journal
HAUTARZT
Volume 65, Issue 7, Pages 623-627
Publisher
Springer Nature
Online
2014-06-12
DOI
10.1007/s00105-014-2839-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumour Necrosis Factor-alpha and Matrix Metalloproteinase-2 are Expressed Strongly in Hidradenitis Suppurativa
- (2013) E Mozeika et al. ACTA DERMATO-VENEREOLOGICA
- Adalimumab for the Treatment of Moderate to Severe Hidradenitis Suppurativa
- (2013) Alexa B. Kimball et al. ANNALS OF INTERNAL MEDICINE
- Impaired Notch signalling: the unifying mechanism explaining the pathogenesis of hidradenitis suppurativa (acne inversa)
- (2012) B.C. Melnik et al. BRITISH JOURNAL OF DERMATOLOGY
- Systemic therapy with immunosuppressive agents and retinoids in hidradenitis suppurativa: a systematic review
- (2012) J.L. Blok et al. BRITISH JOURNAL OF DERMATOLOGY
- S1-Leitlinie zur Therapie der Hidradenitis suppurativa/Acne inversa* (ICD-10 Ziffer: L73.2)
- (2012) Christos C. Zouboulis et al. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
- γ-Secretase Mutations in Hidradenitis Suppurativa: New Insights into Disease Pathogenesis
- (2012) Andrew E. Pink et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Incidence of Hidradenitis Suppurativa and Associated Factors: A Population-Based Study of Olmsted County, Minnesota
- (2012) Benjamin G. Vazquez et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Increased Prevalence of Metabolic Syndrome in Patients with Acne Inversa
- (2012) Robert Sabat et al. PLoS One
- Hidradenitis Suppurativa
- (2011) Brigitte Dr éno ARCHIVES OF DERMATOLOGY
- The aetiology of acne inversa: an evolving story
- (2011) J.R. Ingram BRITISH JOURNAL OF DERMATOLOGY
- A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa
- (2011) I. Miller et al. BRITISH JOURNAL OF DERMATOLOGY
- Smoker’s Boils
- (2011) Rudolf Happle et al. DERMATOLOGY
- Profound disturbances of sexual health in patients with acne inversa
- (2011) Agata Kurek et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Hidradenitis suppurativa/acne inversa: bilocated epithelial hyperplasia with very different sequelae
- (2010) M. von Laffert et al. BRITISH JOURNAL OF DERMATOLOGY
- Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: A randomized, double-blind, placebo-controlled crossover trial
- (2010) Annika Grant et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity
- (2009) K. Sartorius et al. BRITISH JOURNAL OF DERMATOLOGY
- Hidradenitis suppurativa (acne inversa): early inflammatory events at terminal follicles and at interfollicular epidermis*
- (2009) Maximilian von Laffert et al. EXPERIMENTAL DERMATOLOGY
- Clinical characteristics of a series of 302 French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severity
- (2009) Florence Canoui-Poitrine et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Hidradenitis suppurativa: A comprehensive review
- (2009) Ali Alikhan et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Epidermal Notch signalling: differentiation, cancer and adhesion
- (2008) Fiona M Watt et al. CURRENT OPINION IN CELL BIOLOGY
- Acne inversa
- (2008) Daniela Meixner et al. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
- Prevalence and factors associated with hidradenitis suppurativa: Results from two case-control studies
- (2008) Jean E. Revuz et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started